MedTrace Logo

A Study to Investigate the Effect of YM150 on the Plasma Concentration of Digoxin in Healthy Subjects

NCT01514812 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2012-01-24

No results posted yet for this study

Summary

This study is to evaluate the effect of YM150 on the plasma concentration of digoxin in healthy subjects.

Conditions

  • Healthy
  • Pharmacokinetic of Digoxin

Interventions

DRUG

YM150

oral - modified release formulation of YM150

DRUG

placebo

oral

DRUG

digoxin

oral

Sponsors & Collaborators

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Use Central Contact · Astellas Pharma Inc

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2006-04-30
Completion
2006-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01514812 on ClinicalTrials.gov